N-(2-二乙胺基乙基)-5-(5-氟-2-氧代-1,2-二氢吲哚-3-基亚甲基)-2,4-二甲基-1H-吡咯-3-甲酰胺
更新时间：2024-01-03 11:45:22
N-(2-二乙胺基乙基)-5-(5-氟-2-氧代-1,2-二氢吲哚-3-基亚甲基)-2,4-二甲基-1H-吡咯-3-甲酰胺结构式
|
常用名 | N-(2-二乙胺基乙基)-5-(5-氟-2-氧代-1,2-二氢吲哚-3-基亚甲基)-2,4-二甲基-1H-吡咯-3-甲酰胺 | 英文名 | Sunitinib |
|---|---|---|---|---|
| CAS号 | 342641-94-5 | 分子量 | 398.474 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 572.1±50.0 °C at 760 mmHg | |
| 分子式 | C22H27FN4O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 299.8±30.1 °C |
| 中文名 | N-(2-二乙胺基乙基)-5-(5-氟-2-氧代-1,2-二氢吲哚-3-基亚甲基)-2,4-二甲基-1H-吡咯-3-甲酰胺 |
|---|---|
| 英文名 | N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| 中文别名 | 5-(5-氟-2-氧代-1,2-二氢-吲哚-3-基亚甲基)-2,4-二甲基-1H-吡咯-3-羧酸-(2-二乙胺基乙基)酰胺 |
| 英文别名 | 更多 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 572.1±50.0 °C at 760 mmHg |
| 分子式 | C22H27FN4O2 |
| 分子量 | 398.474 |
| 闪点 | 299.8±30.1 °C |
| 精确质量 | 398.211792 |
| PSA | 77.23000 |
| LogP | 3.15 |
| 蒸汽压 | 0.0±1.6 mmHg at 25°C |
| 折射率 | 1.611 |
| 海关编码 | 2933990090 |
|---|
|
~%
N-(2-二乙胺基乙基)-5-... 342641-94-5 |
| 文献：WO2010/49449 A2, ; Page/Page column 16; 17 ; |
|
~45%
N-(2-二乙胺基乙基)-5-... 342641-94-5 |
| 文献：RATIOPHARM GMBH; CHRIST, Jochen; STRIEGEL, Hans-Guenter Patent: WO2010/136458 A1, 2010 ; Location in patent: Page/Page column 27; 28 ; |
| 海关编码 | 2933990090 |
|---|---|
| 中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| sunitinibum |
| 1-[carbaMoyl(diethylaMino)Methyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)Methyl]-2,4-diMethyl-1H-pyrrole-3-carboxylic acid |
| bis(N-[2-(diethylaMino)ethyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)Methyl]-2,4-diMethyl-1H-pyrrole-3-carbox |
| 1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl- |
| SU11248 |
| 5-(5-fluoro-2-oxo-1,2-dihydroindole-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide |
| 1H-PYRROLE-3-CARBOXAMIDE,N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-(9CI) |
| Sunitinib |
| N-[2-(diethylamino)ethyl]-5-[-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylicacid(2-diethylamino-ethyl)-am |
| 1H-PYRROLE-3-CARBOXAMIDE,N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL |
| 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylicacid(2-diethylamino-ethyl)-amide |
| N-[2-(Diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
